Leelyn Smith’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Buy |
8,206
+601
| +8% | +$244K | 0.55% | 46 |
|
|
2025
Q1 | $3.78M | Buy |
7,605
+397
| +6% | +$198K | 0.67% | 39 |
|
|
2024
Q4 | $3.75M | Buy |
7,208
+228
| +3% | +$119K | 0.67% | 39 |
|
|
2024
Q3 | $4.32M | Buy |
6,980
+257
| +4% | +$159K | 0.78% | 33 |
|
|
2024
Q2 | $3.72M | Buy |
6,723
+200
| +3% | +$111K | 0.72% | 36 |
|
|
2024
Q1 | $3.79M | Buy |
6,523
+159
| +2% | +$92.4K | 0.76% | 36 |
|
|
2023
Q4 | $3.38M | Buy |
6,364
+486
| +8% | +$258K | 0.74% | 37 |
|
|
2023
Q3 | $2.98M | Buy |
5,878
+290
| +5% | +$147K | 0.73% | 39 |
|
|
2023
Q2 | $2.92M | Buy |
+5,588
| New | +$2.92M | 0.7% | 38 |
|
|
2023
Q1 | – | Sell |
-150
| Closed | -$82.6K | – | 399 |
|
|
2022
Q4 | $82.6K | Buy |
150
+110
| +275% | +$60.6K | 0.02% | 139 |
|
|
2022
Q3 | $20K | Sell |
40
-550
| -93% | -$275K | 0.01% | 231 |
|
|
2022
Q2 | $320K | Buy |
590
+295
| +100% | +$160K | 0.08% | 103 |
|
|
2022
Q1 | $174K | Hold |
295
| – | – | 0.05% | 122 |
|
|
2021
Q4 | $197K | Hold |
295
| – | – | 0.05% | 118 |
|
|
2021
Q3 | $169K | Hold |
295
| – | – | 0.05% | 117 |
|
|
2021
Q2 | $149K | Buy |
295
+11
| +4% | +$5.56K | 0.04% | 133 |
|
|
2021
Q1 | $130K | Hold |
284
| – | – | 0.04% | 149 |
|
|
2020
Q4 | $132K | Sell |
284
-335
| -54% | -$156K | 0.04% | 140 |
|
|
2020
Q3 | $273K | Hold |
619
| – | – | 0.1% | 104 |
|
|
2020
Q2 | $224K | Sell |
619
-197
| -24% | -$71.3K | 0.09% | 109 |
|
|
2020
Q1 | $231K | Sell |
816
-65
| -7% | -$18.4K | 0.12% | 99 |
|
|
2019
Q4 | $289 | Buy |
+881
| New | +$289 | 0.14% | 94 |
|